3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Recurrence
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Hodgkin Disease
1
Interventions
asciminib
15
Cyclophosphamide
13
fludarabine phosphate
10
fludarabine
9
Mycophenolic Acid
9
Whole-Body Irradiation
8
nilotinib
7
Imatinib Mesylate
6
Tacrolimus
5
Sirolimus
5
Dasatinib
5
Cyclosporine
5
bosutinib
4
Peripheral Blood Stem Cell Transplantation
4
Melphalan
4
Thiotepa
3
Granulocyte Colony-Stimulating Factor
3
Cyclosporins
3
Busulfan
3
venetoclax
2
thymoglobulin
2
ruxolitinib
2
ponatinib
2
Stem Cell Transplantation
2
Mesna
2
Magnetic Resonance Spectroscopy
2
Filgrastim
2
treosulfan
1
selinexor
1
plerixafor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Hematopoietic Stem Cell Mobilization
×
90 days
×
Clear all
No trials found.